Dudediligence.

Natera, Inc

NTRANASDAQ · Services-Medical Laboratories
Write an idea

Price
OptionsOpen the Sheet →FilingsNewest: 10-Q, Quarterly reportAug 6 →InsidersNo open-market buys. 12 insiders sold $276.0M, 318 of 346 sales on a 10b5-1 plan.→HoldersJpmorgan Chase & 9.0%BlackRock 7.6%Vanguard 4.3%→PeersClosest companies: BLLN, MYGN, GH→

From the filings

Figures

Revenue
$2.71Blast 12 months
Net income
−$192.3Mlast 12 months
Operating cash flow
$211.0Mlast 12 months
Cash and equivalents
$1.09Bat the last balance sheet
Total debt
$80.3Mat the last balance sheet
Shares outstanding
143.6M shareson issue
Every year and quarter →